Spots Global Cancer Trial Database for doxorubicin hydrochloride
Every month we try and update this database with for doxorubicin hydrochloride cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma | NCT00005959 | Lymphoma | filgrastim rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... | 18 Years - | National Cancer Institute (NCI) | |
| Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma | NCT00736450 | Contiguous Stag... Noncontiguous S... Stage I Adult D... Stage III Adult... Stage IV Adult ... | oblimersen sodi... rituximab cyclophosphamid... doxorubicin hyd... vincristine sul... prednisone biopsy microarray anal... immunohistochem... gene expression... cytogenetic ana... | 19 Years - | University of Nebraska | |
| Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma | NCT00055640 | Lymphoma | rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... microarray anal... | 18 Years - | Case Comprehensive Cancer Center | |
| Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma | NCT00002539 | Sarcoma | filgrastim cisplatin doxorubicin hyd... conventional su... | - 40 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia | NCT02877303 | B Acute Lymphob... B Lymphoblastic... | Blinatumomab Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Inotuzumab Ozog... Laboratory Biom... Mercaptopurine Methotrexate Ofatumumab Prednisone Rituximab Vincristine Sul... | 14 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer | NCT00003927 | Breast Cancer | filgrastim amifostine trih... cyclophosphamid... doxorubicin hyd... paclitaxel peripheral bloo... | 18 Years - 59 Years | City of Hope Medical Center | |
| Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma | NCT00070083 | Lymphoma | oblimersen sodi... rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... | 19 Years - | National Cancer Institute (NCI) | |
| Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease | NCT00000626 | HIV Infections Hodgkin's Disea... | Vinblastine sul... Dacarbazine Filgrastim Bleomycin sulfa... Doxorubicin hyd... | 12 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma | NCT00002803 | Neuroblastoma | cyclophosphamid... doxorubicin hyd... vincristine sul... conventional su... | - 1 Year | National Cancer Institute (NCI) | |
| Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer | NCT00003364 | Lung Cancer | cisplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... radiation thera... | - 74 Years | National Cancer Institute (NCI) | |
| Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma | NCT00070447 | Lymphoma | rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... yttrium Y 90 ib... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | NCT00040690 | Leukemia Lymphoma | filgrastim cyclophosphamid... cytarabine doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate vincristine sul... radiation thera... | 16 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease | NCT00004010 | Lymphoma | bleomycin sulfa... filgrastim ABVD regimen cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisone procarbazine hy... vinblastine sul... vincristine sul... radiation thera... | - 21 Years | Children's Oncology Group | |
| Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes | NCT00007904 | Breast Cancer | filgrastim cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... adjuvant therap... radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma | NCT00055640 | Lymphoma | rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... microarray anal... | 18 Years - | Case Comprehensive Cancer Center | |
| Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer | NCT00063999 | Recurrent Uteri... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri... | Carboplatin Cisplatin Doxorubicin Hyd... Filgrastim Laboratory Biom... Paclitaxel Pegfilgrastim Quality-of-Life... | 18 Years - | GOG Foundation | |
| Chemotherapy in Treating Children With Liver Cancer | NCT00003912 | Liver Cancer | carboplatin cisplatin doxorubicin hyd... conventional su... | - 16 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia | NCT00049569 | L1 Childhood Ac... L2 Childhood Ac... Non-T, Non-B Ch... Recurrent Child... T-cell Childhoo... | cytarabine methotrexate vincristine sul... prednisone pegaspargase doxorubicin hyd... imatinib mesyla... cyclophosphamid... etoposide filgrastim leucovorin calc... asparaginase therapeutic hyd... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Children With Neuroblastoma | NCT00003093 | Neuroblastoma | filgrastim sargramostim carboplatin cyclophosphamid... doxorubicin hyd... etoposide conventional su... neoadjuvant the... | - 20 Years | Children's Oncology Group | |
| Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma | NCT01527149 | Stage I Mantle ... Stage II Contig... Stage II Non-Co... Stage III Mantl... Stage IV Mantle... | Autologous Hema... Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Laboratory Biom... Methotrexate Ofatumumab Vincristine Sul... | 18 Years - 70 Years | Roswell Park Cancer Institute | |
| Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients | NCT00500422 | Solid Tumors | Doxil Gemcitabine Velcade | - | M.D. Anderson Cancer Center | |
| A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS | NCT00000987 | Sarcoma, Kaposi HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Zidovudine | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma | NCT00006184 | Multiple Myelom... | Myeloma Immunog... Bortezomib Cyclophosphamid... Cyclosporine Doxorubicin hyd... Etoposide Fludarabine pho... Prednisone Vincristine Sul... Methotrexate GMCSF (granuloc... GCSF (granulocy... | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma | NCT05922904 | Hodgkin Lymphom... | Brentuximab ved... Doxorubicin Hyd... Pembrolizumab Dacarbazine | 18 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | NCT00032019 | Lymphoma | filgrastim rituximab cyclophosphamid... doxorubicin hyd... etoposide prednisone vincristine sul... | - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma | NCT00408005 | T Acute Lymphob... T Lymphoblastic... | Asparaginase Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Nelarabine Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul... | 1 Year - 30 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides | NCT00002557 | Lymphoma | CHOP regimen doxorubicin hyd... etoposide leucovorin calc... methotrexate | - | National Cancer Institute (NCI) | |
| SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer | NCT00005822 | Breast Cancer | doxorubicin hyd... semaxanib conventional su... radiation thera... tamoxifen | 18 Years - | Case Comprehensive Cancer Center | |
| Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma | NCT00275106 | Lymphoma | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... leucovorin calc... mercaptopurine methotrexate prednisolone thioguanine vincristine sul... radiation thera... | - 21 Years | National Cancer Institute (NCI) | |
| A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder | NCT05137262 | Urothelial Carc... Bladder Cancer | Abiraterone ace... Durvalumab Methotrexate Vinblastine Doxorubicin Hyd... Cisplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients | NCT00500422 | Solid Tumors | Doxil Gemcitabine Velcade | - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer | NCT00003342 | Bladder Cancer Transitional Ce... | filgrastim carboplatin doxorubicin hyd... gemcitabine hyd... paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma | NCT00025428 | Neuroblastoma | carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... adjuvant therap... conventional su... neoadjuvant the... | 1 Year - 18 Years | National Cancer Institute (NCI) | |
| Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas | NCT00043979 | Sarcoma | F-18 Fluorodeox... therapeutic all... cyclophosphamid... cyclosporine doxorubicin hyd... etoposide fludarabine pho... melphalan prednisone sirolimus tacrolimus vincristine sul... peripheral bloo... Filgrastim Peripheral Bloo... | 5 Years - 35 Years | National Institutes of Health Clinical Center (CC) | |
| Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia | NCT00381680 | B-cell Childhoo... L1 Childhood Ac... L2 Childhood Ac... Intermediate Ri... | vincristine sul... prednisone doxorubicin hyd... pegaspargase cytarabine methotrexate dexamethasone etoposide cyclophosphamid... leucovorin calc... filgrastim asparaginase mercaptopurine | 1 Year - 29 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes | NCT00004125 | Breast Cancer | cyclophosphamid... docetaxel doxorubicin hyd... paclitaxel tamoxifen citra... radiation thera... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas | NCT03036904 | Diffuse Large B... High Grade B-Ce... | Venetoclax Rituximab Etoposide Vincristine Sul... Cyclophosphamid... Prednisone Doxorubicin Hyd... | 18 Years - 80 Years | Weill Medical College of Cornell University | |
| Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas | NCT03036904 | Diffuse Large B... High Grade B-Ce... | Venetoclax Rituximab Etoposide Vincristine Sul... Cyclophosphamid... Prednisone Doxorubicin Hyd... | 18 Years - 80 Years | Weill Medical College of Cornell University | |
| Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas | NCT03220022 | AIDS-Related Ly... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... | Cyclophosphamid... Doxorubicin Hyd... Etoposide Filgrastim Ibrutinib Laboratory Biom... Pegfilgrastim Pharmacological... Prednisone Rituximab Vincristine Sul... | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer | NCT04628767 | Renal Pelvis an... | Biopsy Biospecimen Col... Cisplatin Computed Tomogr... Doxorubicin Hyd... Durvalumab Gemcitabine Hyd... Magnetic Resona... Methotrexate Pegfilgrastim Therapeutic Con... Vinblastine Sul... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia | NCT00003217 | Leukemia Lymphoma | filgrastim cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... methotrexate vincristine sul... | - 21 Years | Children's Oncology Group | |
| A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma | NCT05800366 | Lymphoma Lymphoma, Large... | Glofitamab Polatuzumab Rituximab Doxorubicin Hyd... Cyclophosphamid... Prednisone | 18 Years - | Dana-Farber Cancer Institute | |
| Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer | NCT00014222 | Breast Cancer | epoetin alfa filgrastim cyclophosphamid... doxorubicin hyd... epirubicin hydr... fluorouracil paclitaxel | - 60 Years | Canadian Cancer Trials Group | |
| Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma | NCT00567567 | Localized Resec... Localized Unres... Recurrent Neuro... Regional Neurob... Stage 4 Neurobl... Stage 4S Neurob... | Autologous Hema... Carboplatin Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide External Beam R... Filgrastim Isotretinoin Laboratory Biom... Melphalan Peripheral Bloo... Pharmacological... Thiotepa Topotecan Hydro... Vincristine Sul... | - 30 Years | Children's Oncology Group | |
| Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma. | NCT00025597 | Neuroblastoma | carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... conventional su... | - 1 Year | National Cancer Institute (NCI) | |
| Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors | NCT00002610 | Kidney Cancer | dactinomycin filgrastim carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... conventional su... radiation thera... | - 21 Years | Children's Oncology Group | |
| Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia | NCT03488225 | Acute Lymphobla... B Acute Lymphob... B Acute Lymphob... | Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Inotuzumab Ozog... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Ofatumumab Prednisone Rituximab Vincristine Sul... | 16 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma | NCT00086801 | Lymphoma | doxorubicin hyd... gemcitabine hyd... vinblastine fludeoxyglucose... CT scan | 16 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer | NCT00005830 | Endometrial Ade... Endometrial Cle... Endometrial Ser... Stage III Uteri... Stage IV Uterin... | Doxorubicin Hyd... Cisplatin Radiation Thera... | 18 Years - | GOG Foundation | |
| Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer | NCT00980460 | PRETEXT I Hepat... PRETEXT II Hepa... PRETEXT III Hep... PRETEXT IV Hepa... | Cisplatin Dexrazoxane Doxorubicin Hyd... Fluorouracil Irinotecan Hydr... Laboratory Biom... Liver Transplan... Temsirolimus Therapeutic Con... Vincristine Sul... | - 21 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT00002744 | Leukemia | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... mercaptopurine methotrexate pegaspargase prednisone therapeutic hyd... thioguanine vincristine sul... low-LET cobalt-... low-LET photon ... | 1 Year - 9 Years | Children's Oncology Group | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | NCT00002764 | Endometrial Can... Kidney Cancer Metastatic Canc... Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide conventional su... | 16 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy in Treating Patients With Bladder Cancer | NCT00003701 | Bladder Cancer Urethral Cancer | carboplatin cisplatin doxorubicin hyd... methotrexate paclitaxel vinblastine sul... | 0 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor | NCT00047138 | Kidney Cancer | dactinomycin carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 18 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Women With Breast Cancer | NCT00003679 | Breast Cancer | cyclophosphamid... docetaxel doxorubicin hyd... tamoxifen citra... conventional su... radiation thera... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma | NCT00645632 | Sarcoma | cisplatin doxorubicin hyd... ifosfamide methotrexate adjuvant therap... neoadjuvant the... therapeutic con... | - | Mayo Clinic | |
| Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma | NCT00020943 | Lymphoma | filgrastim rituximab carmustine cyclophosphamid... cytarabine doxorubicin hyd... etoposide leucovorin calc... methotrexate prednisone vincristine sul... peripheral bloo... | 18 Years - 69 Years | Alliance for Clinical Trials in Oncology | |
| Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease | NCT00107198 | Ann Arbor Stage... Ann Arbor Stage... Childhood Nodul... | Conventional Su... Cyclophosphamid... Doxorubicin Hyd... Prednisone Radiation Thera... Vincristine Sul... | 1 Month - 21 Years | Children's Oncology Group | |
| Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer | NCT00005908 | Breast Cancer Breast Neoplasm | Docetaxel - Dos... Anastrozole cyclophosphamid... Docetaxel - Dos... Doxorubicin hyd... Tamoxifen Citra... Capecitabine - ... Capecitabine - ... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor | NCT00379340 | Stage III Kidne... Stage IV Kidney... | 3-Dimensional C... Conventional Su... Cyclophosphamid... Dactinomycin Doxorubicin Hyd... Etoposide Vincristine Sul... | - 29 Years | Children's Oncology Group | |
| Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases | NCT00081159 | Metastatic Canc... Prostate Cancer | Doxorubicin hyd... Goserelin aceta... Leuprolide acet... Zoledronic acid orchiectomy strontium chlor... | - | M.D. Anderson Cancer Center | |
| Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma | NCT00410631 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... conventional su... peripheral bloo... iobenguane I 13... radiation thera... | - 21 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer | NCT00309920 | Breast Cancer | darbepoetin alf... cyclophosphamid... docetaxel doxorubicin hyd... epirubicin hydr... fluorouracil | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer | NCT00022230 | Breast Cancer | aldesleukin filgrastim sargramostim therapeutic aut... cyclophosphamid... doxorubicin hyd... paclitaxel | 18 Years - | Roger Williams Medical Center | |
| Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma | NCT00334854 | Childhood Malig... Sarcoma | doxorubicin hyd... ifosfamide adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia | NCT03488225 | Acute Lymphobla... B Acute Lymphob... B Acute Lymphob... | Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Inotuzumab Ozog... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Ofatumumab Prednisone Rituximab Vincristine Sul... | 16 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma | NCT00028886 | Multiple Myelom... | filgrastim recombinant int... cyclophosphamid... dexamethasone doxorubicin hyd... melphalan thalidomide vincristine sul... bone marrow abl... peripheral bloo... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00017225 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide ifosfamide melphalan tretinoin vincristine sul... vindesine autologous bone... conventional su... peripheral bloo... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer | NCT00004175 | Breast Cancer | cyclophosphamid... docetaxel doxorubicin hyd... conventional su... | 18 Years - | Northwestern University | |
| Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors | NCT00039481 | Cardiac Toxicit... Unspecified Chi... | oblimersen sodi... dexrazoxane hyd... doxorubicin hyd... cyclophosphamid... filgrastim laboratory biom... pharmacological... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer | NCT00533936 | Breast Cancer | trastuzumab cyclophosphamid... doxorubicin hyd... fluorouracil paclitaxel adjuvant therap... conventional su... neoadjuvant the... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer | NCT00004237 | Breast Cancer | cyclophosphamid... doxorubicin hyd... epirubicin hydr... mitoxantrone hy... vinorelbine tar... conventional su... radiation thera... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00004188 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... doxorubicin hyd... etoposide isotretinoin melphalan topotecan hydro... vincristine sul... autologous bone... bone marrow abl... conventional su... peripheral bloo... radiation thera... | - 30 Years | Children's Oncology Group | |
| Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) | NCT00023868 | Colorectal Canc... Metastatic Canc... | FOLFIRI regimen cisplatin doxorubicin hyd... fluorouracil irinotecan hydr... leucovorin calc... mitomycin C | 18 Years - 120 Years | American College of Radiology Imaging Network | |
| Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma | NCT00058422 | Lymphoma | darbepoetin alf... filgrastim rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... indium In 111 i... yttrium Y 90 ib... | 60 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma | NCT00002492 | Sarcoma | cisplatin doxorubicin hyd... isolated limb p... conventional su... brachytherapy radiation thera... | 18 Years - 120 Years | University of Miami | |
| Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer | NCT00044993 | Breast Cancer | Ad5CMV-p53 gene docetaxel doxorubicin hyd... conventional su... neoadjuvant the... | 18 Years - | National Cancer Institute (NCI) | |
| Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma | NCT00008242 | Multiple Myelom... | dexamethasone doxorubicin hyd... thalidomide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease | NCT00002714 | Lymphoma | bleomycin sulfa... Stanford V regi... doxorubicin hyd... etoposide mechlorethamine... prednisone vinblastine sul... vincristine sul... radiation thera... | 16 Years - 60 Years | National Cancer Institute (NCI) | |
| Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | NCT00742924 | Sarcoma | cisplatin dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate zoledronic acid adjuvant therap... neoadjuvant the... therapeutic con... filgrastim Mesna | - 40 Years | Children's Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
